Himoto T

No ORCID on file · 1 paper in corpus · active 2022
2022
International journal of molecular sciences ·doi:10.3390/ijms23031667

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is one of the leading causes of cancer-related deaths worldwide. Regorafenib, a multi-kinase inhibitor, is used as a second-line treatment for advanced HC…